FDA advisers vote in favor of authorizing Moderna Covid-19 vaccine for ages 6-17

Vaccine advisers to the US Food and Drug Administration decided unanimously Tuesday in favor of expanding the emergency use authorization of Moderna’s Covid-19 vaccine to include older children and teens, ages 6 to 17, saying it would offer more benefits than risks.

(SOURCE) https://www.cnn.com/2022/06/14/health/moderna-vaccine-for-teens-kids-fda-vrbpac/index.html

Share:


Related Posts

Unvaccinated individuals 14 times more likely to get monkeypox than vaccinated, new US data shows

Eligible individuals who did not receive the monkeypox vaccine were around 14 times...

Americans are concerned about rise of AI and human enhancements, survey finds

More Americans said they are “more concerned than excited” by the increase of...

Leave a Comment

Your email address will not be published. Required fields are marked *

Add Comment *

Name *

Email *

Website